| Sanofi-Aventis (Suisse) SA - Sarclisa 500 mg/25 mL, solution à diluer pour perfusion |
| 67525 | | 02 | | Sarclisa 500 mg/25 mL | | solution à diluer pour perfusion | | L01FC02 | | Isatuximab | | 18.03.2020 | | |
|
| Composition |
| isatuximabum 500 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, aqua ad iniectabile, q.s. ad solutionem pro 25 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Isatuximabum | 500mg / 25ml |
| | BAG: Active Agent | Dose |
|---|
| Isatuximabum | 500 mg |
| | | | Inactive agents |
|---|
| Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | 2246.60 | 2459.75 | A | SL | No |
|
